Annual Total Liabilities
$9.29 M
-$966.10 K-9.42%
31 December 2022
Summary:
Zynerba Pharmaceuticals annual total liabilities is currently $9.29 million, with the most recent change of -$966.10 thousand (-9.42%) on 31 December 2022. During the last 3 years, it has fallen by -$4.62 million (-33.21%).ZYNE Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$11.46 M
+$1.79 M+18.47%
30 June 2023
Summary:
Zynerba Pharmaceuticals quarterly total liabilities is currently $11.46 million, with the most recent change of +$1.79 million (+18.47%) on 30 June 2023.ZYNE Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZYNE Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -33.2% | +1.3% |
| 5 y5 years | -4.5% | +23.1% |
ZYNE Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -52.8% | -44.5% |
Zynerba Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $11.46 M(+18.5%) |
| Mar 2023 | - | $9.67 M(+4.1%) |
| Dec 2022 | $9.29 M(-9.4%) | $9.29 M(-3.3%) |
| Sept 2022 | - | $9.61 M(-1.6%) |
| June 2022 | - | $9.77 M(+6.0%) |
| Mar 2022 | - | $9.21 M(-10.2%) |
| Dec 2021 | $10.26 M(-26.3%) | $10.26 M(-9.3%) |
| Sept 2021 | - | $11.31 M(+7.7%) |
| June 2021 | - | $10.50 M(-19.8%) |
| Mar 2021 | - | $13.09 M(-5.9%) |
| Dec 2020 | $13.91 M(+14.3%) | $13.91 M(+31.7%) |
| Sept 2020 | - | $10.57 M(-19.1%) |
| June 2020 | - | $13.06 M(+26.7%) |
| Mar 2020 | - | $10.30 M(-15.3%) |
| Dec 2019 | $12.17 M(+25.1%) | $12.17 M(+30.8%) |
| Sept 2019 | - | $9.30 M(-6.8%) |
| June 2019 | - | $9.99 M(+33.4%) |
| Mar 2019 | - | $7.49 M(-23.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $9.73 M(+20.0%) | $9.73 M(+6.4%) |
| Sept 2018 | - | $9.14 M(-24.6%) |
| June 2018 | - | $12.12 M(+26.7%) |
| Mar 2018 | - | $9.57 M(+18.1%) |
| Dec 2017 | $8.10 M(+16.3%) | $8.10 M(-3.9%) |
| Sept 2017 | - | $8.43 M(+7.2%) |
| June 2017 | - | $7.86 M(+13.3%) |
| Mar 2017 | - | $6.94 M(-0.4%) |
| Dec 2016 | $6.97 M(+76.9%) | $6.97 M(+28.8%) |
| Sept 2016 | - | $5.41 M(+7.5%) |
| June 2016 | - | $5.03 M(+72.7%) |
| Mar 2016 | - | $2.91 M(-26.0%) |
| Dec 2015 | $3.94 M(-80.0%) | $3.94 M(+45.1%) |
| Sept 2015 | - | $2.71 M(-86.9%) |
| June 2015 | - | $20.65 M(+518.7%) |
| Mar 2015 | - | $3.34 M(-83.0%) |
| Dec 2014 | $19.67 M(+543.3%) | $19.67 M |
| Dec 2013 | $3.06 M | - |
FAQ
- What is Zynerba Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Zynerba Pharmaceuticals?
- What is Zynerba Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Zynerba Pharmaceuticals?
What is Zynerba Pharmaceuticals annual total liabilities?
The current annual total liabilities of ZYNE is $9.29 M
What is the all time high annual total liabilities for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high annual total liabilities is $19.67 M
What is Zynerba Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of ZYNE is $11.46 M
What is the all time high quarterly total liabilities for Zynerba Pharmaceuticals?
Zynerba Pharmaceuticals all-time high quarterly total liabilities is $20.65 M